These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28656617)

  • 1. Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.
    Dargaud Y; Wolberg AS; Gray E; Negrier C; Hemker HC;
    J Thromb Haemost; 2017 Aug; 15(8):1704-1707. PubMed ID: 28656617
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards standardization of clot waveform analysis and recommendations for its clinical applications.
    Shima M; Thachil J; Nair SC; Srivastava A;
    J Thromb Haemost; 2013 Jul; 11(7):1417-20. PubMed ID: 23648068
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application.
    Douxfils J; Morimont L; Bouvy C; de Saint-Hubert M; Devalet B; Devroye C; Dincq AS; Dogné JM; Guldenpfennig M; Baudar J; Larock AS; Lessire S; Mullier F
    J Thromb Haemost; 2019 Aug; 17(8):1273-1287. PubMed ID: 31063645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability of in vitro response to anticoagulants.
    Samama MM
    Thromb Res; 2011 Jan; 127(1):1. PubMed ID: 21075429
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombin generation in clinical conditions.
    Ten Cate H
    Thromb Res; 2012 Mar; 129(3):367-70. PubMed ID: 22079443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography.
    Hacquard M; Perrin J; Lelievre N; Vigneron C; Lecompte T
    Thromb Res; 2011 Jan; 127(1):29-34. PubMed ID: 20850172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of the WHO 2nd International Standard Factor V, plasma (16/374): communication from the SSC of the ISTH.
    Hubbard AR; Thelwell C; Rigsby P;
    J Thromb Haemost; 2019 Apr; 17(4):695-697. PubMed ID: 30730603
    [No Abstract]   [Full Text] [Related]  

  • 8. An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH.
    Pieters M; Philippou H; Undas A; de Lange Z; Rijken DC; Mutch NJ;
    J Thromb Haemost; 2018 May; 16(5):1007-1012. PubMed ID: 29658191
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there value in kinetic modeling of thrombin generation? Yes.
    Mann KG
    J Thromb Haemost; 2012 Aug; 10(8):1463-9. PubMed ID: 22642417
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B.
    Hansson KM; Gustafsson D; Skärby T; Frison L; Berntorp E
    J Thromb Haemost; 2015 Jul; 13(7):1293-300. PubMed ID: 25944555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation is extremely sensitive to preheating conditions.
    De Smedt E; Hemker HC
    J Thromb Haemost; 2011 Jan; 9(1):233-4. PubMed ID: 21062415
    [No Abstract]   [Full Text] [Related]  

  • 12. International collaborative study to establish the World Health Organization 2nd International Standard for Fibrinogen Concentrate (09/242): communication from the SSC of the ISTH.
    Raut S; Hamill M; Heath AB;
    J Thromb Haemost; 2016 Oct; 14(10):2068-2072. PubMed ID: 27660008
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin Generation Assays (TGAs).
    Salvagno GL; Berntorp E
    Methods Mol Biol; 2017; 1646():515-522. PubMed ID: 28804851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma.
    Woodle SA; Shibeko AM; Lee TK; Ovanesov MV
    Thromb Res; 2013 Sep; 132(3):374-80. PubMed ID: 23953593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives.
    Young G; Sørensen B; Dargaud Y; Negrier C; Brummel-Ziedins K; Key NS
    Blood; 2013 Mar; 121(11):1944-50. PubMed ID: 23319573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH.
    Iorio A; Blanchette V; Blatny J; Collins P; Fischer K; Neufeld E
    J Thromb Haemost; 2017 Dec; 15(12):2461-2465. PubMed ID: 29119666
    [No Abstract]   [Full Text] [Related]  

  • 17. The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH.
    Mancuso ME; Bidlingmaier C; Mahlangu JN; Carcao M; Tosetto A;
    J Thromb Haemost; 2018 Oct; 16(10):2106-2110. PubMed ID: 30182468
    [No Abstract]   [Full Text] [Related]  

  • 18. A critical appraisal of one-stage and chromogenic assays of factor VIII activity.
    Peyvandi F; Oldenburg J; Friedman KD
    J Thromb Haemost; 2016 Feb; 14(2):248-61. PubMed ID: 26663865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data management in thrombin generation.
    Hemker HC; Kremers R
    Thromb Res; 2013 Jan; 131(1):3-11. PubMed ID: 23158401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.
    Harenberg J; Marx S; Weiss C; Krämer R; Samama M; Schulman S;
    J Thromb Haemost; 2012 Jul; 10(7):1433-6. PubMed ID: 22947062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.